Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180308 · ClinicalTrials.gov registry record
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 23
- Enrollment target
NCT02180308 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 23 participants.
The verdict
NCT02180308 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The overarching goal of this study is to develop PET/MR techniques to accurately detect nodal metastases for surgical planning and assessment of treatment response.
Interventions
- DEVICE PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-06 |
| Est. Completion | 2018-09-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02180308
The ClinicalTrials.gov registry entry for NCT02180308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT02180308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02180308 about?
NCT02180308 is a clinical study titled "Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI". The overarching goal of this study is to develop PET/MR techniques to accurately detect nodal metastases for surgical planning and assessment of treatment response.
What is the current status of trial NCT02180308?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2014-06. Estimated completion is 2018-09-11.
What interventions are being tested in trial NCT02180308?
The interventions under investigation include: PET/MRI (DEVICE).
Who is sponsoring clinical trial NCT02180308?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.